WHO ICTRP trial

Effects of Topiramate Tablets in Prophylaxis of Febrile Convulsion

IRCT2015010120527N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT2015010120527N1
Public title Effects of Topiramate Tablets in Prophylaxis of Febrile Convulsion
Scientific title Comparison of Oral Topiramate and Diazepam in Prophylaxis of Febrile Convulsion in Case of Children under Two Years with Limitation in Phenobarbital Prescription
Primary sponsor Vice chancellor for research, Hamadan University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of)
Conditions Febrile convulsions. Febrile Convulsions;Febrile Convulsions
Interventions Intervention 1: For treatment group, oral Topiramat at 9 mg/kg of body weight taken daily in two turns was administered. The administration of drug was continued for one year if Febrile Convulsion has not recurred. Intervention 2: For…
Registration date Nov 22, 2015
Target size 32
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations